Zobrazeno 1 - 10
of 584
pro vyhledávání: ''
Autor:
Kenshi Yao, Kentaro Imamura, Toshiharu Ueki, Satoshi Nimura, Takao Kanemitsu, Hiroshi Tanabe, Yoichiro Ono, Akinori Iwashita, Masaki Miyaoka
Publikováno v:
Gastric Cancer. 24:1307-1319
Gastric adenocarcinoma of fundic-gland type (GA-FG) was first proposed as a new entity of gastric adenocarcinoma in 2010. Subsequently, gastric adenocarcinoma of fundic-gland mucosa type (GA-FGM) was reported as a subtype of gastric adenocarcinoma. T
Autor:
Ken-ichi Ito, Azusa Tanimoto, Yasuo Hirono, Yozo Nakazawa, Tomoya Takiguchi, Tomonobu Koizumi, Mitsutoshi Nakada, Ryuji Hayashi, Yoshikazu Nishino, Seiji Yano, Hidetaka Uramoto
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:1153-1158
Background: Malignant pleural mesothelioma (MPM) is a major occupational and environmental neoplasm. The purpose of this study was to validate the clinical and epidemiological factors, diagnosis, and initial treatment among MPM patients.Methods: We s
Publikováno v:
Gastric Cancer. 24:1194-1202
Early detection of gastric cancer (GC) is a critical step for decreasing mortality. The aim of this study was to evaluate the performance of four prediction models for risk stratification in the screening of GC and precancerous lesions among a large,
Autor:
Michele Gallucci, Aldo Brassetti, Mariaconsiglia Ferriero, Giorgio Napodano, Leonardo Misuraca, Roberto Sanseverino, Giuseppe Simone, Fabio Badenchini, Riccardo Mastroianni, Flavia Proietti, Gabriele Tuderti, Alfredo Maria Bove, Umberto Anceschi
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:1151-1157
BACKGROUND Physical activity (PA) is associated with favorable outcomes in prostate cancer (PCa) patients. We assessed its effect on the risk of PCa reclassification (PCaR) during active surveillance. METHODS Anthropometric, demographic, and clinical
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose When only the TNM classification is used to predict survival in gastric cancer (GC) patients, the impact of the degree of lymphadenectomy on the prognosis is neglected. This study aimed to establish a more effective nomogram based on the log
Autor:
Michele Ciccarelli, Nicolò Gennaro, Alexia Bertuzzi, Marco Alloisio, Armando Santoro, Umberto Cariboni, Laura Giordano, Andrea Dipasquale, Vittorio Quagliuolo, Andrea Marrari
Publikováno v:
British Journal of Cancer
Background The impact of active cancer in COVID-19 patients is poorly defined; however, most studies showed a poorer outcome in cancer patients compared to the general population. Methods We analysed clinical data from 557 consecutive COVID-19 patien
Autor:
Jialu Huang, Kun Deng, Shanyan Liu, Meiling Wen, Shuqing Zeng, Jianhong Zuo, Jingwei Yao, Tao Zhu
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:517-525
As a common head and neck tumor, laryngeal cancer has attracted heightened attention for its treatment and prognosis. Surgery and radiotherapy were mainly therapeutic approaches in laryngeal cancer, and intensity-modulated radiotherapy (IMRT) was a p
Autor:
Wei Mu, Matthew B. Schabath, Kenneth L. Gage, Evangelia Katsoulakis, Robert J. Gillies, Christopher J. Whelan
Publikováno v:
Br J Cancer
BACKGROUND: Approximately 50% of cancer patients eventually develop a syndrome of prolonged weight loss (cachexia), which may contribute to primary resistance to immune checkpoint inhibitors (ICI). This study utilised radiomics analysis of (18)F-FDG-
Publikováno v:
Cancer Immunol Immunother
BACKGROUND: Immune checkpoint inhibitors (ICI) blocking inhibitory immune pathways (e.g., programmed cell death protein-1/-ligand1 [PD-1/PD-L1]) have revolutionized cancer therapy for numerous malignancies. There have been an increasing number of cas
Autor:
Kith Pradhan, R. Alejandro Sica, Astha Thakkar, Amit Verma, Sanjay Goel, Zhu Cui, Joseph A. Sparano, Shawn Jindal, Bradley Rockwell, Stuart H. Packer, D. Yitzhak Goldstein, Akash Pradip Shah, Balazs Halmos
Publikováno v:
Nat Cancer
Patients with cancer have been identified in several studies to be at high risk of developing severe COVID-19; however, rates of SARS-CoV-2 IgG seroconversion and its association with cancer types and anti-cancer therapy remain obscure. We conducted